Notice
Recent Posts
Recent Comments
일 | 월 | 화 | 수 | 목 | 금 | 토 |
---|---|---|---|---|---|---|
1 | ||||||
2 | 3 | 4 | 5 | 6 | 7 | 8 |
9 | 10 | 11 | 12 | 13 | 14 | 15 |
16 | 17 | 18 | 19 | 20 | 21 | 22 |
23 | 24 | 25 | 26 | 27 | 28 |
Tags
- LOI
- Acquistion
- case study
- Confidential Agreement
- private equity
- buyout
- OTCBB
- Korea M&A
- LOTTE
- China
- securities
- Bank
- Investment
- capital gate
- Japan Tobacco
- Japan
- nda
- cgi korea
- Malaysia
- taiwan
- Korea
- Letter of intent
- Merger
- China Construction Bank
- M&A
- acquisition
- CA
- hong kong
- PEF
- sk
Archives
- Today
- Total
Korea M&A Corporation
Sinobiomed's Acquisition of Chinese Pharmaceutical Distributor
Sinobiomed Inc. ("Sinobiomed", or "the Company") (OTCBB: SOBM) is pleased to update on the acquisition, by its 82% owned subsidiary, Shanghai Wanxing Bio-pharmaceuticals Co., Ltd. ("Shanghai Wanxing"), of Suzhou Boai Medical Development Co., Ltd. ("Suzhou Boai"). On August 26, 2007, the equity owners of Suzhou Boai holding 90% of the equity of Suzhou Boai formally transferred their equity owners..
News/M&A
2007. 10. 22. 19:08